Awan FT, Yande S, Esterberg L, Nagar SP, Goyal RK, Priyadarshini M. Economic burden in patients (pt) with CLL/SLL (CLL) who received ≥ 2 prior lines of therapy (LOT), including a Bruton tyrosine kinase inhibitor (BTKi): a SEER-Medicare analysis. Poster presented at the ASCO Quality Care Symposium 2023; October 27, 2023. Boston, MA. [abstract] JCO Oncol Pract. 2023 Nov 1; 19(11 Suppl):23-4. doi: 10.1200/OP.2023.19.11_suppl.24
Gnanasakthy A, Norcross L, Clark M, Fitzgerald K. A review of patient-reported outcome considerations in oncologic drug advisory committee meetings (2016-2021). JCO Oncol Pract. 2023 May;19(5):e745-62. doi: 10.1200/OP.22.00774
Yuguero O, Marsal JR, Buti M, Esquerda M, Soler-Gonzalez J. Descriptive study of association between quality of care and empathy and burnout in primary care. BMC Med Ethics. 2017 Sep 26;18(1):54. doi: 10.1186/s12910-017-0214-9
Raspa M, Sacco P, Candrilli SD, Bishop E, Petrillo J. Validity of a condition specific outcome measure for fragile X syndrome: the Aberrant Behaviour Checklist-utility index. J Intellect Disabil Res. 2016 Sep;60(9):844-55. doi: 10.1111/jir.12264
Willett W, Greenland S, MacMahon B, Trichopoulos D, Rothman KJ, Thomas D. The discipline of epidemiology. Science. 1995 Sep 8;269(5229):1325-6. doi: 10.1126/science.7660105
Rothman KJ. Journal policies on conflict of interest. Science. 1993 Sep 24;261(5129):1661. doi: 10.1126/science.8378766